MedTrace Logo

Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

NCT01536899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2018-04-05

No results posted yet for this study

Summary

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.

Several alternative hypotheses will be evaluated in the proposed project:

1. healthier patients may self-select marijuana use;
2. marijuana use may be associated with consequences that create barriers to seeking healthcare;
3. marijuana use may have medicinal value that reduces the need for such care.

Conditions

  • HIV Positive
  • Marijuana Smoking

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Wayne State University

    lead OTHER

Principal Investigators

  • Mark Greenwald, PhD · Wayne State University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01536899 on ClinicalTrials.gov